Literature DB >> 31805010

Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1/RAB4 expression and mTOR activation.

Aparna Godavarthy1, Ryan Kelly1, John Jimah1, Miguel Beckford1, Tiffany Caza1,2, David Fernandez1,2, Nick Huang1,3, Manuel Duarte1, Joshua Lewis1, Hind J Fadel4, Eric M Poeschla4, Katalin Banki5, Andras Perl1,2,3.   

Abstract

Overexpression and long terminal repeat (LTR) polymorphism of the HRES‑1/Rab4 human endogenous retrovirus locus have been associated with T cell activation and disease manifestations in systemic lupus erythematosus (SLE). Although genomic DNA methylation is diminished overall in SLE, its role in HRES-1/Rab4 expression is unknown. Therefore, we determined how lupus-associated polymorphic rs451401 alleles of the LTR regulate transcription from the HRES-1/Rab4 promoter and thus affect T cell activation. The results showed that cytosine-119 is hypermethylated while cytosine-51 of the promoter and the LTR enhancer are hypomethylated in SLE. Pharmacologic or genetic inactivation of DNA methyltransferase 1 augmented the expression of HRES-1/Rab4. The minimal promoter was selectively recognized by metabolic stress sensor NRF1 when cytosine-119 but not cytosine-51 was methylated, and NRF1 stimulated HRES-1/Rab4 expression in human T cells. In turn, IRF2 and PSIP1 bound to the LTR enhancer and exerted control over HRES-1/Rab4 expression in rs451401 genotype- and methylation-dependent manners. The LTR enhancer conferred markedly greater expression of HRES-1/Rab4 in subjects with rs451401CC over rs451401GG alleles that in turn promoted mechanistic target of rapamycin (mTOR) activation upon T cell receptor stimulation. HRES-1/Rab4 alone robustly activated mTOR in human T cells. These findings identify HRES-1/Rab4 as a methylation- and rs451401 allele-dependent transducer of environmental stress and controller of T cell activation.

Entities:  

Keywords:  Immunology; Lupus; Rheumatology; T cells

Mesh:

Substances:

Year:  2020        PMID: 31805010      PMCID: PMC7030820          DOI: 10.1172/jci.insight.134010

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  63 in total

1.  Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication.

Authors:  Frauke Christ; Arnout Voet; Arnaud Marchand; Stefan Nicolet; Belete A Desimmie; Damien Marchand; Dorothée Bardiot; Nam Joo Van der Veken; Barbara Van Remoortel; Sergei V Strelkov; Marc De Maeyer; Patrick Chaltin; Zeger Debyser
Journal:  Nat Chem Biol       Date:  2010-05-16       Impact factor: 15.040

2.  Possible association between multiple sclerosis and the human T cell leukemia virus (HTLV)-related endogenous element, HRES-1.

Authors:  H B Rasmussen; A Heltberg; K Christensen; J Clausen
Journal:  Mult Scler       Date:  1996-10       Impact factor: 6.312

3.  TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity.

Authors:  Qian Yang; Ken Inoki; Eunjung Kim; Kun-Liang Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-20       Impact factor: 11.205

4.  Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose.

Authors:  V S Vallet; M Casado; A A Henrion; D Bucchini; M Raymondjean; A Kahn; S Vaulont
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

5.  A novel haplotype of the endogenous retrovirus, HRES-1, in patients with multiple sclerosis and healthy individuals.

Authors:  H B Rasmussen; J Clausen
Journal:  Autoimmunity       Date:  1999       Impact factor: 2.815

Review 6.  T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.

Authors:  Vaishali R Moulton; George C Tsokos
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

7.  A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2.

Authors:  H Ge; Y Si; A P Wolffe
Journal:  Mol Cell       Date:  1998-12       Impact factor: 17.970

8.  interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).

Authors:  Kerrie B Bouker; Todd C Skaar; David R Fernandez; Kerry A O'Brien; Rebecca B Riggins; Donghua Cao; Robert Clarke
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

9.  Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.

Authors:  A Hanamura; J F Cáceres; A Mayeda; B R Franza; A R Krainer
Journal:  RNA       Date:  1998-04       Impact factor: 4.942

10.  Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors.

Authors:  Jie Wang; Jiali Zhuang; Sowmya Iyer; XinYing Lin; Troy W Whitfield; Melissa C Greven; Brian G Pierce; Xianjun Dong; Anshul Kundaje; Yong Cheng; Oliver J Rando; Ewan Birney; Richard M Myers; William S Noble; Michael Snyder; Zhiping Weng
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

View more
  3 in total

1.  Metabolic Targets for Treatment of Autoimmune Diseases.

Authors:  Paramarjan Piranavan; Manjeet Bhamra; Andras Perl
Journal:  Immunometabolism       Date:  2020-03-31

Review 2.  Association of Viral Infection With the Development and Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Shigeru Iwata; Yoshiya Tanaka
Journal:  Front Med (Lausanne)       Date:  2022-02-25

Review 3.  T Cell Homeostatic Proliferation Promotes a Redox State That Drives Metabolic and Epigenetic Upregulation of Inflammatory Pathways in Lupus.

Authors:  Ralph C Budd; Christopher D Scharer; Ramiro Barrantes-Reynolds; Scott Legunn; Karen A Fortner
Journal:  Antioxid Redox Signal       Date:  2021-11-09       Impact factor: 8.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.